Who
Itschak Shrem
Director
Company insider
Files Form 4 as: Director, SciSparc; Director, Breedit.
In numbers
- Trades disclosed
- 5
- Buys
- 1
- Sells
- 1
- Bought
- $18K
- Sold
- $9,240
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 4 Mar 2014
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | SPRC SciSparcBiotechnology | SEC FORM 4 Sold | $4,620462 at $10.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | SPRC SciSparcBiotechnology | SEC FORM 4 Sold | $4,620462 at $10.00 | filing |
| 24 Aug 2015filed 26 Aug 2015 | Breedit | SEC FORM 4 Bought | $18K1,800,000 at $0.01 | filing |
| 25 Jan 2015filed 29 Apr 2015 | Breeditoption or derivative | SEC FORM 4 Code A | —2,000,000 at $0.00 | filing |
| 4 Mar 2014filed 22 May 2014 | Breeditoption or derivative | SEC FORM 4 Code A | —1,400,000 at $0.00 | filing |
News
SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette SyndromeSPRC · manilatimes.net · 22 Oct 2026SciSparc Shifts Focus to Agentic AI, Targeting Cybersecurity and Finance ApplicationsSPRC · manilatimes.net · 19 Oct 2026SciSparc Announces Transformation into Agentic AI-Powered Technologies, Including Cybersecurity and Finance TechnologiesSPRC · manilatimes.net · 15 Oct 2026
0 headlines in the last 90 days name Itschak Shrem; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.
Sectors
Related people
Nobody else traded the same names lately.